Brief: Pure Biologics Gets 3.0 Mln Zloty Subsidy For PB004 Drug Development Project
19/06/2020 10:46
June 19 (Reuters) - Pure Biologics SA PUR1.WA :
* GETS 3.0 MILLION ZLOTYS ADVANCE FROM POLAND'S NATIONAL
CENTRE
FOR RESEARCH AND DEVELOPMENT FOR PB004 DRUG DEVELOPMENT PROJECT
Source text for Eikon: ID:nEM94c7pGa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects